Bruker's Revenue in the fiscal year 2025 $ 3,435.70 millions
Bruker's Revenue in the fiscal year 2024 $ 3,366.40 millions
Bruker's Revenue in the fiscal year 2023 $ 2,964.50 millions
Bruker's Revenue in the fiscal year 2022 $ 2,530.70 millions
Bruker's Revenue in the fiscal year 2021 $ 2,417.90 millions
BRKR Revenue third quarter 2026 Y/Y Growth Comment
Bruker Corporation reported Revenue growth of 1.58% year on year in the third quarter 2026, to $ 874.00 millions, this is lower than Bruker Corporation's recent average Revenue growth of 7.19%.
Looking into third quarter 2026 results within Laboratory Analytical Instruments industry 8 other companies have achieved higher Revenue growth. While Bruker Corporation' s Revenue increase of 1.58% ranks overall at the positon no. 2262 in the third quarter 2026.
Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026
Bruker's Q/Q Revenue Growth
Revenue Q/Q Growth Statistics
High
Average
Low
34.14 %
2.77 %
-30.41 %
(Dec 31 2010)
BRKR's III. Quarter Q/Q Revenue Comment
Bruker Corporation achieved in the III. Quarter 2026 above company average sequential Revenue growth of 4.23%, to $ 874.00 millions, from $838.50 millions in the second quarter.
Within Laboratory Analytical Instruments industry 4 other companies have achieved higher Revenue quarter on quarter growth. While Bruker's Revenue growth quarter on quarter, overall rank is 1499.
Bruker Corporation achieved in the III. Quarter 2026 above company average sequential Revenue growth of 4.23%, to $ 874.00 millions, from $838.50 millions in the second quarter.
Within Laboratory Analytical Instruments industry 4 other companies have achieved higher Revenue quarter on quarter growth. While Bruker's Revenue growth quarter on quarter, overall rank is 1499.
Although Bruker's Annual Revenue growth year on year were below company's average 6.52% , Revenue announced in the Sep 30 2026 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 2.16% year on year, from 1.67% in Jun 30 2026.
In the Healthcare sector 206 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 1107 to 1124.
Although Bruker's Annual Revenue growth year on year were below company's average 6.52% , Revenue announced in the Sep 30 2026 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 2.16% year on year, from 1.67% in Jun 30 2026.
In the Healthcare sector 206 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 1107 to 1124.
About Bruker Revenue Growth Rates (BRKR), Current and Historic Growth - CSIMarket Analysis
How we calculate this
This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years).
Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
2.27%